The Advisory team at AMPEL BioSolutions provides expert guidance on the development and commercialization of laboratory-developed tests (LDTs) that predict disease status, identify molecular pathways, and recommend optimal drug options. Their insights ensure alignment with clinical needs and regulatory standards.
View all